University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Julian Hong, MD, MS

Julian Hong, MD, MS

Assistant Professor in Residence, Department of Radiation Oncology and Bakar Computational Health Sciences Institute, UCSF

Cancer Center Program Memberships

Prostate Cancer

Education

Stanford University, Stanford, CA, BS, 06/2008, Biomedical Computation
Stanford University, Stanford, CA, MS, 06/2009, Bioengineering
University of Wisconsin-Madison, Madison, WI, MD, 05/2014, Medicine
Yale-New Haven Medical Center, New Haven/Waterbury, CT, Internship, 06/2015, Internal Medicine
Duke University Medical Center, Durham, NC, Residency, 06/2019, Radiation Oncology


Professional Experience

  • 2014 - 2015
    Intern, Internal Medicine, Yale-New Haven Medical Center/Waterbury Hospital Internal Medicine Residency Program
  • 2015 - 2019
    Resident, Department of Radiation Oncology, Duke University Medical Center
  • 2019 - present
    Assistant Professor, Department of Radiation Oncology and Bakar Computational Health Sciences Institute, UCSF
  • 2019 - present
    Director of Clinical Informatics, Department of Radiation Oncology, UCSF

Honors & Awards

  • 2020
    New England Journal of Medicine Travel Scholarship, Symposium on Artificial Intelligence for Learning Health Systems
  • 2018
    3rd Place, Google Kaggle NCAA March Madness Machine Learning Competition
  • 2014
    Dylan Cappel Memorial Scholarship in Oncology, University of Wisconsin
  • 2012
    Herman and Gwendolyn Shapiro Excellence in Student Research Award, University of Wisconsin
  • 2011
    Excellence in Radiology Research Award, National Student Research Forum
  • 2009
    Excellence in Science Award, American Association for the Advancement of Science

Selected Publications

  1. Sullivan BA, Redding TS, Hauser ER, Gellad ZF, Qin X, Gupta S, Robertson DJ, Weiss DG, O'Leary MC, Madison AN, Sims KJ, Williams CD, Hong JC, Lieberman D, Provenzale D. High-Risk Adenomas at Screening Colonoscopy Remain Predictive of Future High-Risk Adenomas Despite an Intervening Negative Colonoscopy. Am J Gastroenterol. 2020 May 28.
    View on PubMed
  2. Fairchild AT, Tanksley JP, Tenenbaum JD, Palta M, Hong JC. Interrater Reliability in Toxicity Identification: Limitations of Current Standards. Int J Radiat Oncol Biol Phys. 2020 May 03.
    View on PubMed
  3. Spiegel DY, Boyer MJ, Hong JC, Williams CD, Kelley MJ, Salama JK, Palta M. Survival Advantage With Adjuvant Chemotherapy for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis. J Natl Compr Canc Netw. 2020 01; 18(1):52-58.
    View on PubMed
  4. Lafata KJ, Zhou Z, Liu JG, Hong J, Kelsey CR, Yin FF. An Exploratory Radiomics Approach to Quantifying Pulmonary Function in CT Images. Sci Rep. 2019 08 08; 9(1):11509.
    View on PubMed
  5. Hong JC, Salama JK. Authors' Reply. J Natl Compr Canc Netw. 2019 08 01; 17(8):xxxixa-xl.
    View on PubMed
  6. Jacobs CD, Carpenter DJ, Hong JC, Havrilesky LJ, Sosa JA, Chino JP. Radiation Records in the National Cancer Database: Variations in Coding and/or Practice Can Significantly Alter Survival Results. JCO Clin Cancer Inform. 2019 05; 3:1-9.
    View on PubMed
  7. Hong JC, Boyer MJ, Spiegel DY, Williams CD, Tong BC, Shofer SL, Moravan MJ, Kelley MJ, Salama JK. Increasing PET Use in Small Cell Lung Cancer: Survival Improvement and Stage Migration in the VA Central Cancer Registry. J Natl Compr Canc Netw. 2019 02; 17(2):127-139.
    View on PubMed
  8. Lafata KJ, Hong JC, Geng R, Ackerson BG, Liu JG, Zhou Z, Torok J, Kelsey CR, Yin FF. Association of pre-treatment radiomic features with lung cancer recurrence following stereotactic body radiation therapy. Phys Med Biol. 2019 01 08; 64(2):025007.
    View on PubMed
  9. Wang C, Zhu X, Hong JC, Zheng D. Artificial Intelligence in Radiotherapy Treatment Planning: Present and Future. Technol Cancer Res Treat. 2019 01 01; 18:1533033819873922.
    View on PubMed
  10. Zheng D, Hong JC, Wang C, Zhu X. Radiotherapy Treatment Planning in the Age of AI: Are We Ready Yet? Technol Cancer Res Treat. 2019 Jan-Dec; 18:1533033819894577.
    View on PubMed
  11. Hong JC, Niedzwiecki D, Palta M, Tenenbaum JD. Predicting Emergency Visits and Hospital Admissions During Radiation and Chemoradiation: An Internally Validated Pretreatment Machine Learning Algorithm. JCO Clin Cancer Inform. 2018 12; 2:1-11.
    View on PubMed
  12. Spiegel DY, Hong JC, Oyekunle T, Waters L, Lee WR, Salama JK, Koontz BF. A Nomogram for Testosterone Recovery After Combined Androgen Deprivation and Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2019 03 15; 103(4):834-842.
    View on PubMed
  13. Lafata K, Cai J, Wang C, Hong J, Kelsey CR, Yin FF. Spatial-temporal variability of radiomic features and its effect on the classification of lung cancer histology. Phys Med Biol. 2018 11 08; 63(22):225003.
    View on PubMed
  14. Spiegel DY, Boyer MJ, Hong JC, Williams CD, Kelley MJ, Moore H, Salama JK, Palta M. Long-term Clinical Outcomes of Nonoperative Management With Chemoradiotherapy for Locally Advanced Rectal Cancer in the Veterans Health Administration. Int J Radiat Oncol Biol Phys. 2019 03 01; 103(3):565-573.
    View on PubMed
  15. Ackerson BG, Tong BC, Hong JC, Gu L, Chino J, Trotter JW, D'Amico TA, Torok JA, Lafata K, Chang C, Kelsey CR. Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC. Lung Cancer. 2018 11; 125:185-191.
    View on PubMed
  16. Hong JC, Spiegel DY, Havrilesky LJ, Chino JP. High-volume providers and brachytherapy practice: A Medicare provider utilization and payment analysis. Brachytherapy. 2018 Nov - Dec; 17(6):906-911.
    View on PubMed
  17. Tandberg DJ, Cui Y, Rushing CN, Hong JC, Ackerson BG, Marin D, Zhang X, Czito BG, Willett CW, Palta M. Intratreatment Response Assessment With 18F-FDG PET: Correlation of Semiquantitative PET Features With Pathologic Response of Esophageal Cancer to Neoadjuvant Chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2018 11 15; 102(4):1002-1007.
    View on PubMed
  18. Hong JC, Cui Y, Patel BN, Rushing CN, Faught AM, Eng JS, Higgins K, Yin FF, Das S, Czito BG, Willett CG, Palta M. Association of Interim FDG-PET Imaging During Chemoradiation for Squamous Anal Canal Carcinoma With Recurrence. Int J Radiat Oncol Biol Phys. 2018 11 15; 102(4):1046-1051.
    View on PubMed
  19. Hong JC, Ayala-Peacock DN, Lee J, Blackstock AW, Okunieff P, Sung MW, Weichselbaum RR, Kao J, Urbanic JJ, Milano MT, Chmura SJ, Salama JK. Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis. PLoS One. 2018; 13(4):e0195149.
    View on PubMed
  20. Hong JC, Foote J, Broadwater G, Sosa JA, Gaillard S, Havrilesky LJ, Chino JP. Data-Derived Treatment Duration Goal for Cervical Cancer: Should 8 Weeks Remain the Target in the Era of Concurrent Chemoradiation? JCO Clin Cancer Inform. 2017 11; 1:1-15.
    View on PubMed

Go to UCSF Profiles, powered by CTSI